THIRD HARMONIC BIO INC. news, videos and press releases
For more news please use our advanced search feature.
THIRD HARMONIC BIO INC. - More news...
THIRD HARMONIC BIO INC. - More news...
- Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
- Third Harmonic Bio Announces Plan of Liquidation and Dissolution
- Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
- Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
- Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
- Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
- Third Harmonic Bio Announces Third Quarter 2024 Financial Results
- Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
- Third Harmonic Bio to Participate in Upcoming Investor Conferences
- Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
- Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
- Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
- Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
- Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
- Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
- Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
- Third Harmonic Bio Announces Third Quarter 2023 Financial Results
- Third Harmonic Bio Announces Leadership Changes
- Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
- Third Harmonic Bio Announces Second Quarter 2023 Financial Results
- Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
- Third Harmonic Bio Announces First Quarter 2023 Financial Results
- Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
- Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria
- Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference
- Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update
- Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
